About Vyaire
Vyaire is a company based in Illinois City (United States) founded in 2016 was acquired by Apax in March 2018. Vyaire has raised $31.53 million across 1 funding round from investors including Apax Partners. The company has 34 employees as of April 05, 2024. Vyaire has completed 4 acquisitions, including Acutronic Medical, Ciel Medical Devices and MIM Germany. Vyaire offers products and services including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS. Vyaire operates in a competitive market with competitors including Plastiflex, Resvent, Third Pole Therapeutics, Spry Therapeutics and OmniSpirant, among others.
- Headquarter Illinois City, United States
- Employees 34 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vyaire Medical Private Limited
- Date of Incorporation 09 Sep, 2016
- Jurisdiction Noida, Uttar Pradesh, India
-
Annual Revenue
$1.76 M (USD)37.12as on Mar 31, 2023
-
Net Profit
$107.07 K (USD)71.91as on Mar 31, 2023
-
EBITDA
$157.92 K (USD)5.74as on Mar 31, 2023
-
Total Equity Funding
$31.53 M (USD)
in 1 rounds
-
Latest Funding Round
$31.53 M (USD), Series B
Jan 29, 2019
- Investors
-
Employee Count
34
as on Apr 05, 2024
-
Investments & Acquisitions
Acutronic Medical
& 3 more
-
Acquired by
Apax
(Mar 19, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vyaire
Vyaire offers a comprehensive portfolio of products and services, including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS.
System for body plethysmography in respiratory diagnostics.
Device for pulmonary and cardiopulmonary stress testing.
Ventilation support for patient respiratory needs.
Portable ventilators for long-term and transport care.
Comprehensive system for neonatal through adult ventilation.
Funding Insights of Vyaire
Vyaire has successfully raised a total of $31.53M through 1 strategic funding round. The most recent funding activity was a Series B round of $31.53 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vyaire
Vyaire has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Apax Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Locked | Locked | Locked |
Investor details for Vyaire
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vyaire
Vyaire has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Acutronic Medical, Ciel Medical Devices and MIM Germany.
Investment portfolio details for Vyaire
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Airway management products are developed for medical applications.
|
Locked | Locked | 2013 | Locked | |
|
Specialized devices are developed to prevent ventilator-associated pneumonia in hospitals.
|
Locked | Locked | 2012 | Locked | |
|
Non-invasive ventilation devices are developed for ENT and thoracic surgery.
|
Locked | Locked | 1981 | Locked |
Complete acquisition details for Vyaire
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Vyaire
Detailed financials for Vyaire
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vyaire Comparisons
Peer comparison for Vyaire
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vyaire
Vyaire operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Plastiflex, Resvent, Third Pole Therapeutics, Spry Therapeutics and OmniSpirant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hose systems and related components are developed and manufactured.
|
|
| Locked | Locked | Locked |
A suite of respiratory healthcare devices is developed.
|
|
| Locked | Locked | Locked |
Developer of devices for cardiopulmonary therapies
|
|
| Locked | Locked | Locked |
Provides innovative health pillows and technologies for infection prevention and comfort.
|
|
| Locked | Locked | Locked |
Developing inhaled regenerative gene therapy for cystic fibrosis and COPD
|
Detailed competitors of Vyaire
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vyaire
Complete news archive for Vyaire
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vyaire
Vyaire was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Vyaire is headquartered in Illinois City, United States. It is registered at Illinois City, Illinois, United States.
Gaurav Agarwal is the current CEO of Vyaire.
Vyaire is a funded company, having raised a total of $31.53M across 1 funding round to date.
As of Apr 05, 2024, the latest employee count at Vyaire is 34.
Annual revenue of Vyaire is $1.76M as on Mar 31, 2023.
Vyaire Medical was formed in 2016 via a joint venture between BD and Apax Partners, based in Illinois City, United States. Operations center on the medical devices sector, with emphasis on respiratory care. Devices for spirometry, pulmonary function testing, metabolic analysis, sleep diagnostics, ventilation support, anesthesia delivery, and patient monitoringincluding ECG, blood pressure, and temperature systemsare produced and supplied to healthcare providers globally.
Vyaire's top competitors include Plastiflex, Third Pole Therapeutics and Ventec Life Systems.
Vyaire offers Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS.
Vyaire has made 4 acquisitions, including Acutronic Medical, Ciel Medical Devices, and MIM Germany.
Vyaire has 1 investor. Key investors include Apax Partners.